This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Mdxhealth, Sa. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: G Bea A Wisman: Innovator in Cervical Cancer Research
Introduction
G Bea A Wisman is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of cervical cancer research, holding 2 patents that focus on innovative methods for diagnosis and monitoring.
Latest Patents
Wisman’s latest patents include groundbreaking work on the methylation of the EPB41L3 gene. This invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. The methods involve determining the methylation status or the expression levels of specific genes, or a combination thereof. Another patent focuses on the detection and prognosis of cervical cancer, utilizing similar methodologies to enhance diagnostic accuracy.
Career Highlights
Throughout his career, Wisman has worked with various companies, including Mdxhealth SA. His work has been pivotal in advancing the understanding and treatment of cervical cancer, contributing to improved patient outcomes.
Collaborations
Wisman has collaborated with notable professionals in his field, including Wim Van Criekinge and Valerie Deregowski, who is a woman. These collaborations have further enriched his research and innovations.
Conclusion
G Bea A Wisman stands out as an influential inventor in the realm of cervical cancer research, with his patents paving the way for advancements in diagnosis and treatment. His contributions are vital to the ongoing fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile